Dr. Isabel Jimeno Sanz's professional career has been focused on Family and Community Medicine. Based on her extensive experience in this field, as well as in management tasks, she has become the Director of the Isla de Oza Health Center in Madrid.  

At the same time, this expert stands out in research, being the main specialist in Clinical Trial studies related to the safety and immunogenicity of the vaccine against Herpes Zoster (HZ/su) of GSK Biologicals for adults aged 50 years and older. She has also participated in a project to address the early prevention of Microvascular Diabetes and its complications in people with Hyperglycemia in Europe. 

On the other hand, she collaborates and belongs to different groups of the  Madrid Ministry of Health for the revision of the Portfolio of Standardized Services of the same. Also, with the VHP platform of Madrid, the Technical Group of COVID and the Neumoexpertos Group. She is also responsible for the Head of the Vaccine Group of SEMG.  

• Director and Family Doctor at the Isla de Oza Health Center
• Collaborator with different groups of the Madrid Ministry of Health
• Head of the SEMG Vaccine Group
• Specialist in the CAM Vaccine Advisory Committee and in the VHP Platform of Madrid
• Principal Researcher in Clinical Trials 
• Master's Degree in Epidemiology and Public Health from the Autonomous University of Madrid 
• Master's Degree in Dietetics and Nutrition from the University of Navarra
• Degree in Medicine and Surgery from the Complutense University of Madrid
• Diploma in Leadership and Management of PC Teams, Autonomous University of Madrid
• Member of the Neumoexperto Group